Neurodegeneration in Hepatic and Neurologic Wilson's Disease.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
08 2021
Historique:
revised: 23 11 2020
received: 16 06 2020
accepted: 02 12 2020
pubmed: 15 12 2020
medline: 6 1 2022
entrez: 14 12 2020
Statut: ppublish

Résumé

Clinical presentation of Wilson disease (WD) includes hepatic and neurologic manifestations. This study compares subcortical brain regions by magnetic resonance imaging in patients with WD and without neurological symptoms. Distinct atrophy affecting the basal ganglia, accumbens, and hippocampus was present in neurological WD. Cerebellar atrophy was observed in hepatic WD without neurological symptoms.

Identifiants

pubmed: 33316133
doi: 10.1002/hep.31681
pmc: PMC8453945
pii: 01515467-202108000-00041
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1117-1120

Informations de copyright

© 2020 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.

Références

Bandmann O, Weiss KH, Kaler SG. Wilson's disease and other neurological copper disorders. Lancet Neurol 2015;14:103‐113.
Ferenci P, Stremmel W, Członkowska A, Szalay F, Viveiros A, Stättermayer AF, et al. Age and sex but not ATP7B genotype effectively influence the clinical phenotype of Wilson disease. Hepatology 2019;69:1464‐1476.
Czlonkowska A, Tarnacka B, Moller JC, Leinweber B, Bandmann O, Woimant F, et al. Unified Wilson's Disease Rating Scale—a proposal for the neurological scoring of Wilson's disease patients. Neurol Neurochir Pol 2007;41:1‐12.
Yu XE, Gao S, Yang RM, Han YZ. MR imaging of the brain in neurologic Wilson disease. Am J Neuroradiol 2019;40:178‐183.
Dezortova M, Lescinskij A, Dusek P, Herynek V, Acosta‐Cabronero J, Bruha R, et al. Multiparametric quantitative brain MRI in neurological and hepatic forms of Wilson's disease. J Magn Reson Imaging 2020;51:1829‐1835.

Auteurs

André Viveiros (A)

Department of Medicine IMedical University and University Hospital of InnsbruckInnsbruckAustria.

Vincent Beliveau (V)

Department of NeurologyMedical University and University Hospital of InnsbruckInnsbruckAustria.

Marlene Panzer (M)

Department of Medicine IMedical University and University Hospital of InnsbruckInnsbruckAustria.

Benedikt Schaefer (B)

Department of Medicine IMedical University and University Hospital of InnsbruckInnsbruckAustria.

Bernhard Glodny (B)

Department of RadiologyMedical University and University Hospital of InnsbruckInnsbruckAustria.

Benjamin Henninger (B)

Department of RadiologyMedical University and University Hospital of InnsbruckInnsbruckAustria.

Herbert Tilg (H)

Department of Medicine IMedical University and University Hospital of InnsbruckInnsbruckAustria.

Heinz Zoller (H)

Department of Medicine IMedical University and University Hospital of InnsbruckInnsbruckAustria.

Christoph Scherfler (C)

Department of NeurologyMedical University and University Hospital of InnsbruckInnsbruckAustria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH